Literature DB >> 26817581

Increase in frequencies of circulating Th-17 cells correlates with microbial translocation, immune activation and exhaustion in HIV-1 infected patients with poor CD4 T-cell reconstitution.

Ranjini Valiathan1, Deshratn Asthana2.   

Abstract

We analyzed the association of circulating Th-17 cells (cTh-17) with immune activation (IA), immune exhaustion (IE) and regulatory T-cells (T-regs) in 20 human immunodeficiency virus-1 (HIV-1) infected patients with impaired restoration of CD4 T-cell counts despite prolonged suppression of plasma viremia (discordant) and compared it with 20 HIV-1 infected patients showing good immunologic and virologic responses (concordant) following highly active antiretroviral therapy (HAART). Discordant HIV-1 infected patients showed significantly higher frequencies of cTh-17 cells compared to concordant patients and healthy controls after PMA+Ionomicin stimulation. Discordant patients also showed higher CD4 T-cell immune activation (HLA-DR+CD38+) than concordant patients which directly correlated with microbial translocation. Additionally, CD4 T-cells of discordant patients showed higher frequencies of CD4 T-cells expressing multiple immune exhaustion markers (Tim3+PD-1+) which correlated with immune activation indicating that combined analysis of inhibitory molecules along with PD-1 might be a better predictor for immune exhaustion of CD4 T-cells. Increased cTh-17 cell frequency correlated inversely with CD4 T-cell percentages and absolute counts and directly with CD4 T-cell immune activation and T-reg frequencies. Persistent CD4 T-cell immune activation might favor differentiation of activated CD4 T-cells toward cTh-17 phenotype in discordant patients. Discordant patients had significantly lower baseline CD4 T-cell counts and higher viral load at the initiation of HAART and higher immune activation and immune exhaustion after being on HAART for long time indicating that these factors might be associated with an increase in cTh-17 cell frequency, thus, increasing the risk of disease progression despite virologic control.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  HIV-1; Immune activation (IA); Immune exhaustion (IE); Th-17 (Th-17)

Mesh:

Substances:

Year:  2016        PMID: 26817581     DOI: 10.1016/j.imbio.2016.01.002

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

1.  Microbial Translocation Associated with an Acute-Phase Response and Elevations in MMP-1, HO-1, and Proinflammatory Cytokines in Strongyloides stercoralis Infection.

Authors:  Anuradha Rajamanickam; Saravanan Munisankar; Yukthi Bhootra; Chandrakumar Dolla; Thomas B Nutman; Subash Babu
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 2.  Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.

Authors:  Emmanuel Balandya; Teri Reynolds; Stephen Obaro; Julie Makani
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

3.  Commentary: Sublingual Allergen Immunotherapy in HIV-Positive Patients.

Authors:  Salvatore Chirumbolo
Journal:  Front Immunol       Date:  2016-03-31       Impact factor: 7.561

4.  Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection.

Authors:  Norma Rallón; Marcial García; Javier García-Samaniego; Alfonso Cabello; Beatriz Álvarez; Clara Restrepo; Sara Nistal; Miguel Górgolas; José M Benito
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

Review 5.  Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders.

Authors:  Jatin Machhi; Bhavesh D Kevadiya; Ijaz Khan Muhammad; Jonathan Herskovitz; Katherine E Olson; R Lee Mosley; Howard E Gendelman
Journal:  Mol Neurodegener       Date:  2020-06-05       Impact factor: 14.195

6.  Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction.

Authors:  Malin Holm Meyer-Myklestad; Asle Wilhelm Medhus; Kristina Berg Lorvik; Ingebjørg Seljeflot; Simen Hyll Hansen; Kristian Holm; Birgitte Stiksrud; Marius Trøseid; Johannes Roksund Hov; Dag Kvale; Anne Margarita Dyrhol-Riise; Martin Kummen; Dag Henrik Reikvam
Journal:  J Infect Dis       Date:  2022-02-15       Impact factor: 5.226

7.  HIV-Infected Subjects With Poor CD4 T-Cell Recovery Despite Effective Therapy Express High Levels of OX40 and α4β7 on CD4 T-Cells Prior Therapy Initiation.

Authors:  Isaac Rosado-Sánchez; Inés Herrero-Fernández; Miguel Genebat; Jorge Del Romero; Melchor Riera; Daniel Podzamczer; Julián Olalla; Francesc Vidal; Mª Angeles Muñoz-Fernández; Manuel Leal; Yolanda M Pacheco
Journal:  Front Immunol       Date:  2018-07-18       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.